中华内分泌代谢杂志2018年1月第34卷第1期摇ChinJEndocrinolMetab,January2018,Vol.34,No.1·7·
thebestpracticesintheevaluationandtreatmentofpolycysticovaryresistantpolycysticovarysyndrome[J].HumReprod,2005,20(1):
syndrome鄄part1[J].EndocrPract,2015,21(11):1291鄄1300.DOI:175鄄179.DOI:10.1093/humrep/deh580.
10.4158/ep15748.dsc.[57]TanX,LiS,ChangY,etal.Effectofmetformintreatmentduring
[43]郁琦.多囊卵巢综合征诊治标准专家共识[J].中国实用妇科与pregnancyonwomenwithPCOS:asystematicreviewandmeta鄄analysis
产科杂志,2007,23(6):474.[J].ClinInvestMed,2016,39(4):E120鄄E131.
[44]中国营养学会.中国糖尿病膳食指南(2017)[R].第13届全国[58]AliKhanR,KapurP,JainA,etal.Effectoforlistatonperiostin,
营养科学大会暨全球华人营养科学家大会,2017.adiponectin,inflammatorymarkersandultrasoundgradesoffattyliverin
[45]MoranLJ,HutchisonSK,NormanRJ,etal.LifestylechangesinobeseNAFLDpatients[J].TherClinRiskManag,2017,13:139鄄
womenwithpolycysticovarysyndrome[J].CochraneDatabaseSyst149.DOI:10.2147/tcrm.s124621.
Rev,2011,(2):Cd007506.DOI:10.1002/14651858.[59]CobinRH,GoodmanNF.Americanassociationofclinical
CD007506.pub2.endocrinologistsandamericancollegeofendocrinologyposition
[46]HoegerKM.Roleoflifestylemodificationinthemanagementofstatementonmenopause鄄2017update[J].EndocrPract,2017,23
polycysticovarysyndrome[J].BestPractResClinEndocrinolMetab,(7):869鄄880.DOI:10.4158/ep171828.ps.
2006,20(2):293鄄310.DOI:10.1016/j.beem.2006.03.008.[60]WongVW,ChanWK,ChitturiS,etal.Asia鄄PacificWorkingPartyon
[47]AmericanDiabetesAssociation.Standardsofmedicalcareindiabetes鄄鄄NonalcoholicFattyLiverDiseaseGuidelines2017Part1:Definition,
2014[J].DiabetesCare,2014,37(Suppl1):S14鄄S80.DOI:10.riskfactorsandassessment[J].JGastroenterolHepatol,2018,33
2337/dc14鄄S014.(1):70鄄85.DOI:10.1111/jgh.13857.
[48]KozicaSL,DeeksAA,Gibson鄄HelmME,etal.Health鄄related[61]AmericanbiabetesAssociation.Managementofdiabetesinpregnancy
behaviorsinwomenwithlifestyle鄄relateddiseases[J].BehavMed,[J].DiabetesCare,2015,38(Suppl):S77鄄S79.DOI:10.2337/
2012,38(3):65鄄73.DOI:10.1080/08964289.2012.685498.dc15鄄S015.
[49]LegroRS,ArslanianSA,EhrmannDA,etal.Diagnosisandtreatment[62]SathyapalanT,KilpatrickES,CoadyAM,etal.Theeffectof
ofpolycysticovarysyndrome:anEndocrineSocietyclinicalpracticeatorvastatininpatientswithpolycysticovarysyndrome:arandomized
guideline[J].JClinEndocrinolMetab,2013,98(12):4565鄄double鄄blindplacebo鄄controlledstudy[J].JClinEndocrinolMetab,
4592.DOI:10.1210/jc.2013鄄2350.2009,94(1):103鄄108.DOI:10.1210/jc.2008鄄1750.
[50]GraffSK,MarioFM,ZiegelmannP,etal.Effectsoforlistatvs.[63]DokrasA.Noncontraceptiveuseoforalcombinedhormonal
metforminonweightloss鄄relatedclinicalvariablesinwomenwithPCOS:contraceptivesinpolycysticovarysyndrome鄄risksversusbenefits
systematicreviewandmeta鄄analysis[J].IntJClinPract,2016,70[J].FertilSteril,2016,106(7):1572鄄1579.DOI:10.1016/j.
(6):450鄄461.DOI:10.1111/ijcp.12787.fertnstert.2016.10.027.
[51]MoiniA,KananiM,KashaniL,etal.Effectoforlistatonweightloss,[64]WangQY,SongY,HuangW,etal.Comparisonofdrospirenone鄄with
hormonalandmetabolicprofilesinwomenwithpolycysticovariancyproteroneacetate鄄containingoralcontraceptives,combinedwith
syndrome:arandomizeddouble鄄blindplacebo鄄controlledtrial[J].metforminandlifestylemodificationsinwomenwithpolycysticovary
Endocrine,2015,49(1):286鄄289.DOI:10.1007/s12020鄄014鄄syndromeandmetabolicdisorders:Aprospectiverandomizedcontrol
0426鄄4.trial[J].ChinMedJ(Engl),2016,129(8):883鄄890.DOI:10.
[52]LiXJ,YuYX,LiuCQ,etal.Metforminvsthiazolidinedionesfor4103/0366鄄6999.179783.
treatmentofclinical,hormonalandmetaboliccharacteristicsof[65]GanieMA,Khurana,ML,NisarS,etal.Improvedefficacyoflow鄄dose
polycysticovarysyndrome:ameta鄄analysis[J].ClinEndocrinolspironolactoneandmetformincombinationthaneitherdrugaloneinthe
(Oxf),2011,74(3):332鄄339.DOI:10.1111/j.1365鄄2265.managementofwomenwithpolycysticovarysyndrome(PCOS):asix鄄
2010.03917.x.month,open鄄labelrandomizedstudy[J].JClinEndocrinolMetab,
[53]BrettenthalerN,DeGeyterC,HuberPR,etal.Effectoftheinsulin2013,98(9):3599鄄3607.DOI:10.1210/jc.2013鄄1040.
sensitizerpioglitazoneoninsulinresistance,hyperandrogenism,and[66]ZulianE,SartoratoP,BenediniS,etal.Spironolactoneinthe
ovulatorydysfunctioninwomenwithpolycysticovarysyndrome[J].Jtreatmentofpolycysticovarysyndrome:effectsonclinicalfeatures,
ClinEndocrinolMetab,2004,89(8):3835鄄3840.DOI:10.1210/insulinsensitivityandlipidprofile[J].JEndocrinolInvest,2005,28
jc.2003鄄031737.(1):49鄄53.
[54]ZhengMY,YangJH,ShanCY,etal.Effectsof24鄄weektreatmentwith[67]中华医学会妇产科学分会绝经学组.绝经期管理与激素补充治
acarboseonglucagon鄄likepeptide1innewlydiagnosedtype2diabetic疗临床应用指南(2012版)[J].中华妇产科杂志,2013,48(10):
patients:apreliminaryreport[J].CardiovascDiabetol,2013,12:795鄄799.DOI:10.3760/cma.j.issn.0529鄄567x.2013.10.018.
73.DOI:10.1186/1475鄄2840鄄12鄄73.[68]ThessalonikiESHRE/ASRM鄄SponsoredPCOSConsensusWorkshop
[55]ZhangX,FangZ,ZhangC,etal.EffectsofacarboseonthegutGroup.Consensusoninfertilitytreatmentrelatedtopolycysticovary
microbiotaofprediabeticpatients:Arandomized,double鄄blind,syndrome[J].FertilSteril,2008,89(3):505鄄522.DOI:10.1016/
controlledcrossovertrial[J].DiabetesTher,2017,8(2):293鄄j.fertnstert.2007.09.041.
307.DOI:10.1007/s13300鄄017鄄0226鄄y.(收稿日期:2017鄄09鄄10)
[56]SonmezAS,YasarL,SavanK,etal.Comparisonoftheeffectsof
(本文编辑:周丽斌)
acarboseandmetforminuseonovulationratesinclomiphenecitrate鄄 |
|
